Drug
vanzacaftor, tezacaftor, and deutivacaftor
Marketed as ALYFTREK.
Generic name
vanzacaftor, tezacaftor, and deutivacaftor
Brand names
ALYFTREK
First FDA approval
2024-12-20
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA218730 | ALYFTREK | 2024-12-20 | VERTEX PHARMS INC |
Manufacturers
VERTEX PHARMS INC
Frequently asked questions
When was vanzacaftor, tezacaftor, and deutivacaftor FDA approved?
Earliest FDA approval on record: 2024-12-20.
What brand names are sold as vanzacaftor, tezacaftor, and deutivacaftor?
ALYFTREK.
Sources
Appeal a vanzacaftor, tezacaftor, and deutivacaftor denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com